News & Analysis as of

Regulatory Agenda Trump Administration Coronavirus/COVID-19

Foley Hoag LLP - White Collar Law &...

Year in Preview: Review of and Insights into Investigations by the 119th Congress

This is the fifth in our 2025 Year in Preview series examining important trends in white collar law and investigations in the coming year. We will be posting further installments in the series throughout the next several...more

McDermott+

DEA Releases Long-Awaited Telehealth Special Registration Proposal, but Adoption Is Uncertain

McDermott+ on

On January 15, 2025, the US Drug Enforcement Administration (DEA) released a proposed rule entitled Special Registrations for Telemedicine and Limited State Telemedicine Registrations. This proposed rule would establish three...more

Mintz - Health Care Viewpoints

HIPAA Amendments and Other Trump Regulatory Actions on Hold

In the waning days of the Trump administration, the Office for Civil Rights (“OCR”) announced a number of new initiatives, including proposed HIPAA amendments, and a very recent COVID-19 related Notice of Enforcement...more

Mintz - ML Strategies

ML Strategies Lame Duck Update: Trade and China Tariffs

Mintz - ML Strategies on

With a dwindling number of in-session legislative days before the end of the current 116th Congress, the U.S. House of Representatives and Senate are working to conclude their work before adjourning at the end of the year....more

Foley Hoag LLP

The Health Care Priorities of the Biden Harris Administration and Post Election Outlook for the 117th Congress

Foley Hoag LLP on

In a historic presidential election that began during the COVID-19 pandemic and ended with record voter turnout and mail-in ballots, former Vice President Joseph Biden of Delaware was declared the 46th president of the United...more

Hogan Lovells

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Hogan Lovells on

In Tuesday's Report: FDA warns over drug misbranded as COVID-19 treatment; podcast discusses Trump's "Buy American" executive order; an op-ed on the importance of protecting biomedical innovation; HHS sees high level...more

Hogan Lovells

COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)

Hogan Lovells on

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging time....more

Williams Mullen

Regulatory Prescriptions for COVID-19: Trump Continues Efforts for Regulatory Reform and Expedited Infrastructure Review

Williams Mullen on

Two recent executive orders (“EOs”) issued by President Trump require additional efforts by federal agencies to facilitate regulatory reform and to expedite infrastructure projects, relying greatly on emergency and special...more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – May 2020 #3

Hogan Lovells on

In Washington: Administration officials said that they plan to wind down the coronavirus task force at the end of May and shift management of the public health response back to the federal agencies....more

Hogan Lovells

Coronavirus: The Hill and the Headlines – COVID-19 D.C. Update – May 2020 #2

Hogan Lovells on

In Washington: Vice President Mike Pence told reporters that the administration is winding down and disbanding the White House Coronavirus Task Force around the end of the month.  Officials say that key medical experts will...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide